CR
ProgramCRI Technology Impact Award
Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.
About
Applications run in two stages: a Letter of Intent, then an invited full proposal for candidates CRI selects by mid-February. Winning projects receive seed funding of up to $600,000 over two to four years, plus indirect costs of up to 10% of the award paid to the institution. Awards can only start on the first of a month, no earlier than July 1.
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.